Sign In
Buy ABEO
$6.42
-0.0500 (-0.773%)
At Close: Jul 31, 2026
Cowen & Co. Maintains a Buy Rating on IVERIC bio (ISEE) - Markets
12:47pm, Wednesday, 17'th Jun 2020
Cowen & Co. analyst Ken Cacciatore maintained a Buy rating on IVERIC bio (ISEE – Research Report) on June 15
4D Molecular Therapeutics Announces New Agreement With Cystic Fibrosis Foundation | | IT Business Net
12:01pm, Wednesday, 17'th Jun 2020
EMERYVILLE, Calif.--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, today announced a
Abeona Therapeutics Further Strengthens Board with Appointment of Two New Independent Directors
11:30am, Wednesday, 17'th Jun 2020
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced Board of Director appointments that strengthen and expand the Company’s leadership. George Migau
4D Molecular Therapeutics Announces New Agreement With Cystic Fibrosis Foundation
12:00am, Wednesday, 17'th Jun 2020
4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, today
AGTC to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference on June 23, 2020
08:01pm, Tuesday, 16'th Jun 2020
Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene
Fox Corp. In “Very, Very Early” Talks With NFL On Rights Reup, COO John Nallen Says, Labeling Cost Critique “Absurd”
03:09pm, Tuesday, 16'th Jun 2020
Fox Corp. COO John Nallen confirmed the company is in “very, very early discussions” with the NFL about renewing its rights deal with the league, a closely watched process that he said …
4D Molecular Therapeutics Raises $75 Million in Series C Financing
12:00am, Tuesday, 16'th Jun 2020
4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, annou
Advantage Oil & Gas Ltd. (TSE:AAV) Director Acquires C$31,200.00 in Stock
07:19am, Sunday, 14'th Jun 2020
Advantage Oil & Gas Ltd. (TSE:AAV) (NYSE:AAV) Director Ronald A. Mcintosh purchased 15,000 shares of the company’s stock in a transaction on Monday, June 8th. The stock was bought at an average pric
BIO: Audentes CEO Holles on keeping the biotech spirit
02:50pm, Thursday, 11'th Jun 2020
When Astellas closed its $3 billion buyout of Audentes Therapeutics, the J.P. Morgan conference crowd was full of “backhanded congratulations.” They offered Natalie Holles, then the newly minted C
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential
EN DIRECT DES MARCHES : Sanofi, Peugeot, Iliad, Soitec, Europlasma, Eli Lilly, Just Eat Takeaway, Tesla, Generali...
09:50am, Thursday, 11'th Jun 2020Global Leukemia Therapeutics Market Forecast and Opportunities to 2025 - ResearchAndMarkets.com
12:00am, Thursday, 11'th Jun 2020
The
Muscular disorder treatment might provide basis for COVID-19 vaccine
08:58pm, Wednesday, 10'th Jun 2020
University of Florida researchers on Wednesday announced plans to repurpose a gene therapy approach used to treat rare neuromuscular diseases for a potential vaccine against COVID-19.
Repligen: Management Gambled With 2020 Guidance But Long-Term Growth Story Looks Compelling (NASDAQ:RGEN)
05:04pm, Wednesday, 10'th Jun 2020
Repligen develops and sells bioprocessing technologies and systems involved in the manufacturing of biological drugs. The company operates within a high growth,
